Assessing the risk of developing psychosis using computer-based methods
5/5 CAPER: Computerized Assessment of Psychosis Risk
This study is looking for people who might be at risk for developing psychotic disorders by using fun online tasks to help spot early signs, making it easier for anyone to join in and get the support they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10794291 on NIH RePORTER |
What this research studies
This research aims to identify individuals at high risk for psychotic disorders by developing a new assessment tool that utilizes computer-based tasks. By focusing on specific symptoms of psychosis and their neurobiological underpinnings, the study seeks to improve the accuracy of early diagnosis and increase accessibility to assessment methods. Participants will engage in inexpensive behavioral tasks that can be administered online, making it easier for those in various locations to participate. The goal is to enhance the predictive value of identifying at-risk individuals and ultimately prevent the onset of psychotic illnesses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are experiencing early signs of psychosis or have attenuated psychotic symptoms.
Not a fit: Patients who are not experiencing any symptoms of psychosis or have already been diagnosed with a psychotic disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate identification of individuals at risk for psychosis, potentially preventing the onset of these disorders.
How similar studies have performed: Previous research has shown promise in using specialized interviews to identify at-risk individuals, but this approach aims to innovate by utilizing computer-based methods, making it a novel approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Corlett, Philip — Yale University
- Study coordinator: Corlett, Philip
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.